Relmada Therapeutics logo

Relmada Therapeutics Share Price Today

(NASDAQ: RLMD)

Relmada Therapeutics share price is $0.26 & ₹22.61 as on 6 Mar 2025, 2.30 'hrs' IST

$0.26

Market is closed - opens 8 PM, 06 Mar 2025

View live Relmada Therapeutics share price in Dollar and Rupees. Guide to invest in Relmada Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Relmada Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Relmada Therapeutics share price movements

  • Today's Low: $0.26
    Today's High: $0.27

    Day's Volatility :4.26%

  • 52 Weeks Low: $0.24
    52 Weeks High: $6.63

    52 Weeks Volatility :96.37%

Relmada Therapeutics (RLMD) Returns

PeriodRelmada Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-41.58%
2.1%
0.0%
6 Months
-89.14%
-4.1%
0.0%
1 Year
-95.89%
2.2%
0.0%
3 Years
-98.75%
11.8%
-11.6%

Relmada Therapeutics (RLMD) Key Statistics

in dollars & INR

Previous Close
$0.2629
Open
$0.2582
Today's High
$0.2697
Today's Low
$0.2582
Market Capitalization
$7.8M
Today's Volume
$71.0K
52 Week High
$6.63
52 Week Low
$0.2404
Revenue TTM
$0.0
EBITDA
$-161.2M
Earnings Per Share (EPS)
$-2.75
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-116.6%

How to invest in Relmada Therapeutics Stock (RLMD) from India?

It is very easy for Indian residents to invest directly in Relmada Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Relmada Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Relmada Therapeutics or RLMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Relmada Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Relmada Therapeutics shares which would translate to 3.345 fractional shares of Relmada Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Relmada Therapeutics, in just a few clicks!

Returns in Relmada Therapeutics (RLMD) for Indian investors in Rupees

The Relmada Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Relmada Therapeutics investment value today

Current value as on today

₹9,025

Returns

₹90,975

(-90.97%)

Returns from Relmada Therapeutics Stock

₹95,938 (-95.94%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Relmada Therapeutics (RLMD)

33%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Relmada Therapeutics Stock from India on INDmoney has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Relmada Therapeutics

  • Franklin Resources Inc

    4.32%

  • Vanguard Group Inc

    4.16%

  • BlackRock Inc

    1.97%

  • Palo Alto Investors, LLC

    1.64%

  • Geode Capital Management, LLC

    1.00%

  • Deutsche Bank AG

    0.75%

Analyst Recommendation on Relmada Therapeutics

Buy

    63%Buy

    36%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Relmada Therapeutics(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
4
4
4
Sell
0
0
0

Analyst Forecast on Relmada Therapeutics Stock (RLMD)

What analysts predicted

Upside of 233.35%

Target:

$0.87

Current:

$0.26

Insights on Relmada Therapeutics Stock (Ticker Symbol: RLMD)

  • Price Movement

    In the last 1 month, RLMD stock has moved down by -30.8%
  • RLMD vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 158.1%
  • RLMD vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 146.4%

Relmada Therapeutics Technicals Summary

Sell

Neutral

Buy

Relmada Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Relmada Therapeutics (RLMD) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Relmada Therapeutics Inc logo
-22.65%
-89.14%
-95.89%
-98.75%
-99.42%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Relmada Therapeutics Inc logo
NA
NA
NA
-1.72
-1.17
-0.69
NA
1.58
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Relmada Therapeutics Inc logo
Buy
$7.8M
-99.42%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Relmada Therapeutics

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system diseases (CNS) and other disorders in the United States. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a N-methyl-D-aspartate receptor antagonist which is in phase 3 clinical trial for the adjunctive or monotherapy treatment of major depressive disorder. The company is headquartered in Coral Gables, Florida.
Organization
Relmada Therapeutics
Employees
20
CEO
Dr. Sergio Traversa M.B.A., Pharm.D.
Industry
Pharmaceuticals: Major

Management People of Relmada Therapeutics

NameTitle
Dr. Sergio Traversa M.B.A., Pharm.D.
CEO & Director
Mr. Maged S. Shenouda M.B.A., R.Ph.
Chief Financial Officer
Mr. Paul E. Kelly M.B.A.
COO & Director
Ms. Gina DiGuglielmo
VP & Head of Clinical Operations
Mr. John Hixon
Head of Commercial
Dr. Andrew Cutler
Senior Clinical Development Advisor
Dr. Richard M. Mangano Ph.D.
Consultant

Important FAQs about investing in RLMD Stock from India :

What is Relmada Therapeutics share price today?

Relmada Therapeutics share price today stands at $0.26, Open: $0.26 ; Previous Close: $0.26 ; High: $0.27 ; Low: $0.26 ; 52 Week High: $6.63 ; 52 Week Low: $0.24.

The stock opens at $0.26, after a previous close of $0.26. The stock reached a daily high of $0.27 and a low of $0.26, with a 52-week high of $6.63 and a 52-week low of $0.24.

Can Indians buy Relmada Therapeutics shares?

Yes, Indians can invest in the Relmada Therapeutics (RLMD) from India.

With INDmoney, you can buy Relmada Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Relmada Therapeutics at zero transaction cost.

How can I buy Relmada Therapeutics shares from India?

It is very easy to buy Relmada Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Relmada Therapeutics (RLMD) be purchased?

Yes, you can buy fractional shares of Relmada Therapeutics with INDmoney app.

What are the documents required to start investing in Relmada Therapeutics stocks?

To start investing in Relmada Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Relmada Therapeutics Stock (RLMD)?

Today’s highest price of Relmada Therapeutics (RLMD) is $0.27.

Today’s lowest price of Relmada Therapeutics (RLMD) is $0.26.

What is today's market capitalisation of Relmada Therapeutics?

Today's market capitalisation of Relmada Therapeutics RLMD is 7.8M

What is the 52 Week High and Low Range of Relmada Therapeutics Stock (RLMD)?

  • 52 Week High

    $6.63

  • 52 Week Low

    $0.24

What are the historical returns of Relmada Therapeutics (RLMD)?

  • 1 Month Returns

    -22.65%

  • 3 Months Returns

    -89.14%

  • 1 Year Returns

    -95.89%

  • 5 Years Returns

    -99.42%

Who is the Chief Executive Officer (CEO) of Relmada Therapeutics ?

Dr. Sergio Traversa M.B.A., Pharm.D. is the current Chief Executive Officer (CEO) of Relmada Therapeutics.